readthroughSign in
CompanyDRUGNasdaqChicago, IL

Bright Minds Biosciences Inc.

Bright Minds develops selective serotonergic agonists for neurological and psychiatric disorders including epilepsy, Prader-Willi Syndrome, and depression.

SCHEDULE 13G/ANov 16Latest SEC filing
Sep 30Latest story

September 2026